{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:21:26Z","timestamp":1795080086159,"version":"4.10.2"},"posted":{"date-parts":[[2026,11,16]]},"group-title":"Neurology","reference-count":99,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T00:00:00Z","timestamp":1794787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Second Century Fund (C2F), Chulalongkorn University","id":[{"id":"https:\/\/ror.org\/028wp3y58","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Center of Excellence in Digital and AI for Mental Health, Chulalongkorn University","id":[{"id":"https:\/\/ror.org\/028wp3y58","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Clinical Research Chair in Evidence-Based Mental Health, University of Ottawa","id":[{"id":"https:\/\/ror.org\/03c4mmv16","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,11,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Mild cognitive impairment (MCI) and mild behavioral impairment (MBI) are overlapping prodromal states associated with dementia risk. Circulating apolipoproteins (Apos) may be linked to cognitive and behavioral changes, but their relationships remain unclear.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Examine plasma concentrations of multiple Apos in prodromal dementia.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    This cross-sectional study included 148 Thai participants aged 60-75 years: 56 cognitively normal controls, 47 with MCI without MBI, and 45 with MBI with or without MCI. We measured ApoA1, ApoA2, ApoB, ApoC1, ApoC3, ApoD, ApoE, ApoH, and ApoJ, five lipids, and\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype, and computed an atherogenic Apo composite (ApoB-ApoC1-ApoC3). Primary analyses used multivariable linear regression of quantitative cognitive and behavioral outcomes. Group comparisons were secondary and served to contextualize the dimensional regression findings.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Across Montreal Cognitive Assessment (MoCA) models, 20.7-28.2% of variance was explained by combinations of ApoH, ApoC3,\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54 carrier status, age, and male sex (inverse associations), and free cholesterol and education (positive associations). The atherogenic composite was inversely associated with MoCA total, memory index, and delayed recall scores, and with Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD) verbal fluency and word list recall. No significant predictors emerged for Neuropsychiatric Inventory (NPI) scores or NPI caregiver distress. All nine Apos differed significantly between groups, with levels highest in MCI, intermediate in MBI, and lowest in controls.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Circulating Apo profiles differed across controls, MCI, and MBI groups and were more consistently associated with cognitive than behavioral outcomes. ApoH and the atherogenic Apo composite warrant further investigation as candidate biomarkers of early cognitive dysfunction.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.11.14.26368084","type":"posted-content","created":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:50:18Z","timestamp":1794887418000},"source":"Crossref","is-referenced-by-count":0,"title":["Circulating Apolipoprotein Profiles and Their Associations with Mild Cognitive and Behavioral Impairment in Older Adults: A Cross-Sectional Study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-5465","authenticated-orcid":false,"given":"Arisara","family":"Amrapala","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Doctor of Philosophy Program in Clinical Sciences (International Program), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Digital and AI for Mental Health (AIMET), Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9016-234X","authenticated-orcid":false,"given":"Solaphat","family":"Hemrungrojn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Digital and AI for Mental Health (AIMET), Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Cognitive Fitness and Biopsychiatry Technology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-6797","authenticated-orcid":false,"given":"Natawut","family":"Nupairoj","sequence":"additional","affiliation":[{"name":"Center of Excellence in Digital and AI for Mental Health (AIMET), Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand"},{"name":"Department of Computer Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-7233","authenticated-orcid":false,"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"The Ottawa Hospital\/Ottawa Hospital Research Institute (OHRI), Ottawa, Ontario, Canada"},{"name":"Department of Child and Adolescent Psychiatry, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9356-1461","authenticated-orcid":false,"given":"Chavit","family":"Tunvirachaisakul","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Cognitive Fitness and Biopsychiatry Technology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"International NIMETOX Center, Sichuan Provincial Center for Mental Health, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"},{"name":"Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria"},{"name":"Research Institute, Medical University of Plovdiv, Plovdiv, Bulgaria"},{"name":"Kyung Hee University, Seoul, Dongdaemun-gu, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026111901100992000_2026.11.14.26368084v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02145-7"},{"key":"2026111901100992000_2026.11.14.26368084v1.2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.3.303"},{"key":"2026111901100992000_2026.11.14.26368084v1.3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1590\/S1980-57642009DN20400004","article-title":"Mild behavioral impairment: A prodromal stage of dementia","volume":"2","year":"2008","journal-title":"Dement Neuropsychol"},{"key":"2026111901100992000_2026.11.14.26368084v1.4","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12190"},{"key":"2026111901100992000_2026.11.14.26368084v1.5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","article-title":"Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment","volume":"12","year":"2016","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026111901100992000_2026.11.14.26368084v1.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.142679"},{"key":"2026111901100992000_2026.11.14.26368084v1.7","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610204000092"},{"key":"2026111901100992000_2026.11.14.26368084v1.8","first-page":"E2132","article-title":"Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms","volume":"98","year":"2022","journal-title":"Neurology"},{"key":"2026111901100992000_2026.11.14.26368084v1.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0218-y"},{"key":"2026111901100992000_2026.11.14.26368084v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00305-3"},{"key":"2026111901100992000_2026.11.14.26368084v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118614"},{"key":"2026111901100992000_2026.11.14.26368084v1.12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41440-019-0357-9","article-title":"Roles of vascular risk factors in the pathogenesis of dementia","volume":"43","year":"2020","journal-title":"Hypertension Research"},{"key":"2026111901100992000_2026.11.14.26368084v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.11.008"},{"key":"2026111901100992000_2026.11.14.26368084v1.14","doi-asserted-by":"publisher","DOI":"10.2174\/15672050113109990037"},{"key":"2026111901100992000_2026.11.14.26368084v1.15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.18.2046"},{"key":"2026111901100992000_2026.11.14.26368084v1.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013124"},{"key":"2026111901100992000_2026.11.14.26368084v1.17","doi-asserted-by":"crossref","unstructured":"Williamson JD , Pajewski NM , Auchus AP , et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia. JAMA 2019; 321: 553.","DOI":"10.1001\/jama.2018.21442"},{"key":"2026111901100992000_2026.11.14.26368084v1.18","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70050"},{"key":"2026111901100992000_2026.11.14.26368084v1.19","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01495-8"},{"key":"2026111901100992000_2026.11.14.26368084v1.20","doi-asserted-by":"crossref","unstructured":"Livingston G , Huntley J , Liu KY , et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet 2024; 404: 572\u2013628.","DOI":"10.1016\/S0140-6736(24)01296-0"},{"key":"2026111901100992000_2026.11.14.26368084v1.21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaneurol.2017.4365","article-title":"Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention","volume":"75","year":"2018","journal-title":"JAMA Neurol"},{"key":"2026111901100992000_2026.11.14.26368084v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2005.01.005"},{"key":"2026111901100992000_2026.11.14.26368084v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)34443-6"},{"key":"2026111901100992000_2026.11.14.26368084v1.24","first-page":"545","article-title":"Apolipoproteins and Alzheimer\u2019s pathophysiology","volume":"10","year":"2018","journal-title":"Alzheimer\u2019s and Dementia: Diagnosis, Assessment and Disease Monitoring"},{"key":"2026111901100992000_2026.11.14.26368084v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117537"},{"key":"2026111901100992000_2026.11.14.26368084v1.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034078"},{"key":"2026111901100992000_2026.11.14.26368084v1.27","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.899175"},{"key":"2026111901100992000_2026.11.14.26368084v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24326"},{"key":"2026111901100992000_2026.11.14.26368084v1.29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajpath.2021.11.013","article-title":"Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele","volume":"192","year":"2022","journal-title":"American Journal of Pathology"},{"key":"2026111901100992000_2026.11.14.26368084v1.30","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01058-9"},{"key":"2026111901100992000_2026.11.14.26368084v1.31","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11060984"},{"key":"2026111901100992000_2026.11.14.26368084v1.32","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01574-w"},{"key":"2026111901100992000_2026.11.14.26368084v1.33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/alz.12442","article-title":"Apolipoprotein B is a novel marker for early tau pathology in Alzheimer\u2019s disease","volume":"18","year":"2022","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026111901100992000_2026.11.14.26368084v1.34","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P119000473"},{"key":"2026111901100992000_2026.11.14.26368084v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32684"},{"key":"2026111901100992000_2026.11.14.26368084v1.36","doi-asserted-by":"publisher","DOI":"10.1002\/alz.046615"},{"key":"2026111901100992000_2026.11.14.26368084v1.37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167908"},{"key":"2026111901100992000_2026.11.14.26368084v1.38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5471-06.2007"},{"key":"2026111901100992000_2026.11.14.26368084v1.39","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/acschemneuro.0c00637","article-title":"Apolipoprotein J in Alzheimer\u2019s Disease: Shedding Light on Its Role with Cell Signaling Pathway Perspective and Possible Therapeutic Approaches","volume":"11","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"2026111901100992000_2026.11.14.26368084v1.40","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9845.1"},{"key":"2026111901100992000_2026.11.14.26368084v1.41","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1007\/s11357-025-01695-6","article-title":"Association of APOC1 with cortical atrophy during conversion to Alzheimer\u2019s disease","volume":"47","year":"2025","journal-title":"Geroscience"},{"key":"2026111901100992000_2026.11.14.26368084v1.42","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-026-01399-y"},{"key":"2026111901100992000_2026.11.14.26368084v1.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2026111901100992000_2026.11.14.26368084v1.44","doi-asserted-by":"publisher","DOI":"10.1017\/S135561772000048X"},{"key":"2026111901100992000_2026.11.14.26368084v1.45","doi-asserted-by":"publisher","DOI":"10.1097\/wad.0000000000000240"},{"key":"2026111901100992000_2026.11.14.26368084v1.46","doi-asserted-by":"publisher","DOI":"10.1159\/000517822"},{"key":"2026111901100992000_2026.11.14.26368084v1.47","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.5_suppl_6.10s"},{"key":"2026111901100992000_2026.11.14.26368084v1.48","doi-asserted-by":"publisher","DOI":"10.1212\/MNL.39.9.1159"},{"key":"2026111901100992000_2026.11.14.26368084v1.49","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e3181b76415"},{"key":"2026111901100992000_2026.11.14.26368084v1.50","first-page":"1","article-title":"CERAD (Consortium to Establish a Registry for Alzheimer\u2019s Disease) Neuropsychology Assessment Battery: 35 Years and Counting","volume":"93","year":"2023","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2026111901100992000_2026.11.14.26368084v1.51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/PRBM.S447774","article-title":"Distress Symptoms of Old Age and Mild Cognitive Impairment are Two Distinct Dimensions in Older Adults Without Major Depression","volume":"17","year":"2024","journal-title":"Psychol Res Behav Manag"},{"key":"2026111901100992000_2026.11.14.26368084v1.52","first-page":"1445","article-title":"Neurocognitive Features of Mild Cognitive Impairment and Distress Symptoms in Older Adults Without Major Depression","volume":"19","year":"2024","journal-title":"Clin Interv Aging"},{"key":"2026111901100992000_2026.11.14.26368084v1.53","doi-asserted-by":"publisher","DOI":"10.2196\/29001"},{"key":"2026111901100992000_2026.11.14.26368084v1.54","doi-asserted-by":"publisher","DOI":"10.1017\/S104161021700151X"},{"key":"2026111901100992000_2026.11.14.26368084v1.55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","article-title":"Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment","volume":"12","year":"2016","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2026111901100992000_2026.11.14.26368084v1.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102668"},{"key":"2026111901100992000_2026.11.14.26368084v1.57","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v15.i9.108910"},{"key":"2026111901100992000_2026.11.14.26368084v1.58","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/13872877241291231","article-title":"Mild behavioral impairment in people with mild cognitive impairment: Are the two conditions related?","volume":"102","year":"2024","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2026111901100992000_2026.11.14.26368084v1.59","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-333819"},{"key":"2026111901100992000_2026.11.14.26368084v1.60","doi-asserted-by":"publisher","DOI":"10.1002\/alz.073459"},{"key":"2026111901100992000_2026.11.14.26368084v1.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2015.02.012"},{"key":"2026111901100992000_2026.11.14.26368084v1.62","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/13803395.2026.2647965","article-title":"Associations of anxiety and worry symptoms with cognitive performance among midlife women: importance of APOE4 genotype status","volume":"48","year":"2026","journal-title":"J Clin Exp Neuropsychol"},{"key":"2026111901100992000_2026.11.14.26368084v1.63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052645"},{"key":"2026111901100992000_2026.11.14.26368084v1.64","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neubiorev.2018.11.020","article-title":"Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer\u2019s disease dementia: A systematic review and meta-analysis","volume":"96","year":"2019","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"2026111901100992000_2026.11.14.26368084v1.65","doi-asserted-by":"crossref","unstructured":"Rao AR , Thakral M , Saini M , et al. Blood biomarkers in older subjects with mild behavioral impairment: A cross-sectional study from the memory clinic, all india institute of medical sciences, India. Journal of the Indian Academy of Geriatrics 2020; 16: 91.","DOI":"10.4103\/jiag.jiag_7_20"},{"key":"2026111901100992000_2026.11.14.26368084v1.66","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1002\/alz.13902","article-title":"Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adults","volume":"20","year":"2024","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"2026111901100992000_2026.11.14.26368084v1.67","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3233\/JAD-230898","article-title":"Mild Behavioral Impairment and Cerebrovascular Profiles Are Associated with Early Cognitive Impairment in a Community-Based Southeast Asian Cohort","volume":"97","year":"2024","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2026111901100992000_2026.11.14.26368084v1.68","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14020080"},{"key":"2026111901100992000_2026.11.14.26368084v1.69","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000361043","article-title":"Total cholesterol and neuropsychiatric symptoms in Alzheimer\u2019s disease: The impact of total cholesterol level and gender","volume":"38","year":"2014","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2026111901100992000_2026.11.14.26368084v1.70","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2025.1586418"},{"key":"2026111901100992000_2026.11.14.26368084v1.71","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1534193"},{"key":"2026111901100992000_2026.11.14.26368084v1.72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S1807-59322011000100020","article-title":"Relationship between depression and apolipoproteins A and B: A case-control study","volume":"66","year":"2011","journal-title":"Clinics"},{"key":"2026111901100992000_2026.11.14.26368084v1.73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05390-1"},{"key":"2026111901100992000_2026.11.14.26368084v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00378-4"},{"key":"2026111901100992000_2026.11.14.26368084v1.75","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4525"},{"key":"2026111901100992000_2026.11.14.26368084v1.76","doi-asserted-by":"crossref","unstructured":"Ren H , Liu Z , Zhou X , et al. Association of sleep duration with apolipoproteins and the apolipoprotein B\/A1 ratio: the China health and nutrition survey. Nutr Metab (Lond ) 2018; 15: 1.","DOI":"10.1186\/s12986-017-0237-8"},{"key":"2026111901100992000_2026.11.14.26368084v1.77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2017.02.017","article-title":"Plasma apolipoproteins and physical and cognitive health in very old individuals","volume":"55","year":"2017","journal-title":"Neurobiol Aging"},{"key":"2026111901100992000_2026.11.14.26368084v1.78","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3233\/JAD-140111","article-title":"Apolipoprotein C-III is an amyloid-\u03b2-binding protein and an early marker for Alzheimer\u2019s disease","volume":"41","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"2026111901100992000_2026.11.14.26368084v1.79","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3233\/JAD-181096","article-title":"Higher Apolipoprotein C-III Levels in Cerebrospinal Fluid are Associated with Slower Cognitive Decline in Mild Cognitive Impairment","volume":"67","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2026111901100992000_2026.11.14.26368084v1.80","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/NDT.S238985","article-title":"Higher plasma apoc-iii was associated with a slower reduction of \u03b2-amyloid levels in cerebrospinal fluid among older individuals without dementia","volume":"16","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2026111901100992000_2026.11.14.26368084v1.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.09.072"},{"key":"2026111901100992000_2026.11.14.26368084v1.82","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/CS20070308","article-title":"Apolipoprotein C-III: understanding an emerging cardiovascular risk factor","volume":"114","year":"2008","journal-title":"Clin Sci"},{"key":"2026111901100992000_2026.11.14.26368084v1.83","first-page":"18","article-title":"Plasma apolipoprotein J as a potential biomarker for Alzheimer\u2019s disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer\u2019s and Dementia: Diagnosis","volume":"3","year":"2016","journal-title":"Assessment and Disease Monitoring"},{"key":"2026111901100992000_2026.11.14.26368084v1.84","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060790"},{"key":"2026111901100992000_2026.11.14.26368084v1.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577996"},{"key":"2026111901100992000_2026.11.14.26368084v1.86","first-page":"e12008","article-title":"Plasma Lipids as Biomarkers for Alzheimer\u2019s Disease: A Systematic Review","volume":"12","year":"2020","journal-title":"Cureus"},{"key":"2026111901100992000_2026.11.14.26368084v1.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.119159"},{"key":"2026111901100992000_2026.11.14.26368084v1.88","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-016-0701-6"},{"key":"2026111901100992000_2026.11.14.26368084v1.89","unstructured":"Streja E , Feingold KR. Evaluation and Treatment of Dyslipidemia in the Elderly. In: Feingold K , Adler R , Ahmed S (eds) Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc., 2000."},{"key":"2026111901100992000_2026.11.14.26368084v1.90","doi-asserted-by":"crossref","unstructured":"Weverling-Rijnsburger AW , Blauw GJ , Margot Lagaay A , et al. Total cholesterol and risk of mortality in the oldest old Articles Introduction. 1997.","DOI":"10.1016\/S0140-6736(97)04430-9"},{"key":"2026111901100992000_2026.11.14.26368084v1.91","doi-asserted-by":"publisher","DOI":"10.1037\/neu0000335"},{"key":"2026111901100992000_2026.11.14.26368084v1.92","first-page":"1","article-title":"Association Between Ratio of Triglycerides to HDL-C and Cognitive Impairment: A Longitudinal Population-Based Analysis and Mendelian Randomization Study","volume":"34","year":"2026","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"2026111901100992000_2026.11.14.26368084v1.93","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040406"},{"key":"2026111901100992000_2026.11.14.26368084v1.94","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R800090-JLR200"},{"key":"2026111901100992000_2026.11.14.26368084v1.95","doi-asserted-by":"publisher","DOI":"10.1126\/science.294.5545.1354"},{"key":"2026111901100992000_2026.11.14.26368084v1.96","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-014-0131-3"},{"key":"2026111901100992000_2026.11.14.26368084v1.97","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86610"},{"key":"2026111901100992000_2026.11.14.26368084v1.98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1997.tb00198.x"},{"key":"2026111901100992000_2026.11.14.26368084v1.99","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.838223"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.11.14.26368084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:10:33Z","timestamp":1795079433000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.11.14.26368084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,16]]},"references-count":99,"URL":"https:\/\/doi.org\/10.64898\/2026.11.14.26368084","relation":{},"subject":[],"published":{"date-parts":[[2026,11,16]]},"subtype":"preprint"}}